CRISIL
|
CRISIL Last 5 Year Financial Ratios History
[Consolidated]
| Dec2023 | Dec2022 | Dec2021 | Dec2020 | Dec2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 90.07 | 77.21 | 63.90 | 48.86 | 47.57 |
| CEPS(Rs) | 104.27 | 91.34 | 78.43 | 65.54 | 52.67 |
| DPS(Rs) | 54.00 | 48.00 | 46.00 | 33.00 | 32.00 |
| Book NAV/Share(Rs) | 295.31 | 240.64 | 210.30 | 173.14 | 152.87 |
| Tax Rate(%) | 24.12 | 23.98 | 24.68 | 22.60 | 30.03 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 28.08 | 26.35 | 26.54 | 25.77 | 26.32 |
| EBIT Margin(%) | 27.75 | 27.04 | 27.27 | 23.85 | 28.40 |
| Pre Tax Margin(%) | 27.64 | 26.81 | 26.88 | 23.12 | 28.39 |
| PAT Margin (%) | 20.97 | 20.38 | 20.25 | 17.90 | 19.86 |
| Cash Profit Margin (%) | 24.28 | 24.12 | 24.85 | 24.01 | 21.99 |
| Performance Ratios | |||||
| ROA(%) | 22.02 | 21.72 | 15.56 | 10.98 | 12.19 |
| ROE(%) | 33.61 | 34.29 | 33.39 | 30.03 | 31.64 |
| ROCE(%) | 43.77 | 44.43 | 43.41 | 38.02 | 42.52 |
| Asset Turnover(x) | 1.05 | 1.07 | 0.77 | 0.61 | 0.61 |
| Sales/Fixed Asset(x) | 2.68 | 2.36 | 1.98 | 2.33 | 3.38 |
| Working Capital/Sales(x) | 2.88 | 3.39 | 3.64 | 5.01 | 3.68 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.37 | 0.42 | 0.50 | 0.43 | 0.30 |
| Receivable days | 84.19 | 85.68 | 67.30 | 46.66 | 51.03 |
| Inventory Days | - | - | - | - | - |
| Payable days | - | - | - | - | - |
| Valuation Parameters | |||||
| PER(x) | 48.18 | 39.72 | 45.16 | 39.35 | 40.15 |
| PCE(x) | 41.62 | 33.57 | 36.79 | 29.34 | 36.27 |
| Price/Book(x) | 14.69 | 12.74 | 13.72 | 11.11 | 12.50 |
| Yield(%) | 1.24 | 1.57 | 1.59 | 1.72 | 1.68 |
| EV/Net Sales(x) | 9.99 | 7.98 | 9.02 | 6.90 | 7.78 |
| EV/Core EBITDA(x) | 32.15 | 25.93 | 30.17 | 23.04 | 25.48 |
| EV/EBIT(x) | 35.98 | 29.51 | 33.06 | 28.94 | 27.38 |
| EV/CE(x) | 14.32 | 12.33 | 8.48 | 3.86 | 4.61 |
| M Cap / Sales | 10.10 | 8.10 | 9.14 | 7.04 | 7.98 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 13.39 | 20.34 | 16.09 | 14.44 | -0.96 |
| Core EBITDA Growth(%) | 14.44 | 23.94 | 15.79 | 12.32 | -2.93 |
| EBIT Growth(%) | 16.37 | 19.36 | 32.73 | -3.89 | -1.99 |
| PAT Growth(%) | 16.66 | 21.16 | 31.31 | 3.13 | -5.27 |
| EPS Growth(%) | 16.66 | 20.83 | 30.77 | 2.71 | -5.54 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.08 | 1.87 | 1.79 | 1.48 | 1.84 |
| Quick Ratio(x) | 2.08 | 1.87 | 1.79 | 1.48 | 1.84 |
| Interest Cover(x) | 238.08 | 117.00 | 70.25 | 32.85 | 2,138.35 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of CRISIL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CRISIL | ₹38,309.5 Cr | -0.7% | -4.3% | 23.2% | Stock Analytics | |
| ICRA | ₹6,372.6 Cr | -1.3% | -8.9% | 22.8% | Stock Analytics | |
| CARE RATINGS | ₹4,481.2 Cr | -0.8% | 2.5% | 62.3% | Stock Analytics | |
CRISIL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CRISIL | -0.7% |
-4.3% |
23.2% |
| SENSEX | 1.1% |
1.1% |
22.2% |
You may also like the below Video Courses
